PVR and melanoma: Although surface expression of CD155 can induce NK cell activation, melanoma cells secrete a soluble form of CD155 that inhibits CD226-mediated NK cell cytotoxicity [58], which may explain the correlation between CD155 expression and negative melanoma prognostic markers such as metastatic emergence and treatment resistance [59,60].